Single-nucleotide Polymorphisms in Genes Encoding Toll-like Receptor -2, -3, -4, and -9 in a Case-Control Study with Bladder Cancer Susceptibility in a North Indian Population

Archives of Medical Research

Volumn 44, Issue 1, 2013, Pages 54-61

  Singh, Vibha ^a   Srivastava, Neena ^b   Kapoor, Rakesh ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Bacillus Calmette Guerin; Bladder cancer; PCR RFLP; TLR gene polymorphism

Indexed keywords

BCG VACCINE; CISPLATIN; GEMCITABINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; CYSTECTOMY; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 3 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 9 GENE;

ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS; URINARY BLADDER NEOPLASMS;

EID: 84873174177     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.10.008     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Shariat S.F., Sfakianos J.P., Droller M.J., et al. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010, 105:300-308.
3. Sinha R., Anderson D.E., McDonald S.S., et al. Cancer risk and diet in India. J Postgrad Med 2003, 49:222-228.
4. Kaufman D.S., Shipley W.U., Feldman A.S. Bladder cancer. Lancet 2009, 374:239-249.
5. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
6. Krieg A.M., Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007, 220:251-269.
7. Wang R.F., Miyahara Y., Wang H.Y. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 2008, 27:181-189.
8. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388:621-625.
9. Pasare C., Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005, 560:11-18.
10. Misch E.A., Hawn T.R. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 2008, 114:347-360.
11. Schwartz D.A., Cook D.N. Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis 2005, 41(suppl 7):S403-S407.
12. El-Omar E.M., Ng M.T., Hold G.L. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 2008, 27:244-252.
13. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
14. Noguchi E., Nishimura F., Fukai H., et al. An association study of asthma and total serum Immunoglobulin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004, 34:177-183.
15. Pandey S., Mittal R.D., Srivastava M., et al. Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol 2009, 3:501-515.
16. Srivastava K., Srivastava A., Kumar A., et al. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int 2010, 30:1067-1072.
17. Junpee A., Tencomnao T., Sanprasert V., et al. Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis. Parasitol Res 2010, 4:807-816.
18. Arbour N.C., Lorenz E., Schutte B.C. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
19. Pandey S., Agrawal D.K. Immunobiology of Toll-like 413 receptors: emerging trends. Immunol Cell Biol 2006, 84:333-341.
20. Chang A.H., Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev 2010, 23:837-857.
21. Colombel M., Soloway M., Akaza H. Epidemiology, staging, grading and risk stratification of bladder cancer. Euro Urol Suppl 2008, 7:618-626.
22. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988, 16:1215.
23. Tahara T., Arisawa T., Wang F. Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 2007, 98:1790-1794.
24. Cheng P.L., Eng H.L., Chou M.H., et al. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res 2007, 150:311-318.
25. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002, 1:103-110.
26. Turvey S.E., Hawn T.R. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol 2006, 1:1-9.
27. Janeway C.A., Medzhitov R., et al. Innate immune recognition. Annu Rev Immunol Cell Biol 2002, 20:197-216.
28. Mandal R.K., George G.P., Mittal R.D. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 2012, 39:7263-7269.
29. Srivastava P., Singh A., Kesarwani P., et al. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India. Clin Transplant 2012.
30. Pandey S., Mittal B., Srivastava M., et al. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 2011, 38:4715-4721.
31. He J.F., Jia W.H., Fan Q., et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007, 7:194.
32. Etokebe G.E., Knezevic J., Petricevic B., et al. Single-nucleotide polymorphisms in genes encoding Toll-like receptor-2, -3, -4, and -9 in case-control study with breast cancer. Genet Test Mol Biomarkers 2009, 13:729-734.
33. Davoodi H., Seow H.F. Variant toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and toll-like receptor2 (Arg753Gln and Arg677Trp Alleles) in colorectal cancer. Iran J Allergy Asthma Immunol 2011, 10:91-99.
34. Balistreri C.R., Caruso C., Carruba G., et al. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications. Curr Pharm Des 2010, 16:718-724.
35. Mollaki V., Georgiadis T., Tassidou A., et al. Polymorphisms and haplotypes in TLR 9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study. J Hum Genet 2009, 54:655-659.
36. Li J., Tao J.H., Gao W., et al. Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis. Mod Rheumatol 2012.